DOJ Rescheduling Preview | Virginia Amending Adult Use | Illinois Introduces Hemp Ban?

DOJ Rescheduling Preview | Virginia Amending Adult Use | Illinois Introduces Hemp Ban?

Author: Cannabis Radio June 24, 2026 Duration: 20:58

We report on a wave of highly targeted legislative, legal, and medical updates aimed at curbing market disorder and protecting public health.

In the United States, Virginia has advanced a budget deal to its governor establishing a definitive July 2027 timeline for adult-use dispensary sales, while Illinois has enacted precise safety guardrails by banning intoxicating hemp sales to minors and enforcing strict child-proof packaging. This regulatory tightening faces immediate constitutional hurdles in the courts, where Ninth Circuit judges are currently deadlocked over whether sweeping state bans on cannabis billboard advertisements violate free speech.

Meanwhile, international markets are facing severe enforcement crises; Thailand’s Ministry of Public Health has rolled out an aggressive penalty framework targeting rule-breaking dispensaries with immediate license suspensions, and Canada’s regulated sector is suffering such severe economic pressure from a deeply entrenched illicit market that a major national cannabis organization was forced to suspend its operations.

Underpinning these legislative shifts is an escalating medical concern highlighted by The Epoch Times, which details how high-potency THC stores itself long-term in bodily fat and organs, continuously triggering low-grade, system-wide immune inflammation even after active consumption stops.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 50

Blunt Business
Podcast Episodes
Future of Cannabusiness: Brand Strategy and Industry Consolidation [not-audio_url] [/not-audio_url]

Duration: 32:33
Joe Bayern with MM Brands outlines a strategic roadmap for professionalizing the cannabis industry, emphasizing that sustainable growth requires moving beyond fragmented operations. Key strategies include adopting a port…
The Ongoing Federal Rescheduling and Operational Hurdles in Cannabis [not-audio_url] [/not-audio_url]

Duration: 25:22
Blunt Business welcomes Joe Bayern, the CEO of MM Brands to discuss how the cannabis industry is approaching a potential turning point as DOJ and DEA hearings conclude this July, with anticipation high for a move to Sche…
Banking, Compliance, and the DOJ Hearing for Cannabis Rescheduling [not-audio_url] [/not-audio_url]

Duration: 29:09
Once again we welcome back Nick Richards, Partner and co-chair of the cannabis law practice group at Greenspoon Marder about how the cannabis and hemp industries currently face a complex landscape defined by existential…
Clarifying Cannabis From THCA Loopholes to Schedule III Shifts [not-audio_url] [/not-audio_url]

Duration: 40:52
Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis and hemp sectors. She clarifies the critical distinction between THC…
Kazmira Therapeutics and the Future of CBD Medicine [not-audio_url] [/not-audio_url]

Duration: 28:24
Kazmira Therapeutics is revolutionizing the CBD landscape by transitioning cannabinoids from over-the-counter health supplements to precision, pharmacist-compounded "real medicine". Led by co-founders Dr. Priyanka Sharma…
Georgia Expands Medical Access and D.C. Beats Cannabis Lawsuit [not-audio_url] [/not-audio_url]

Duration: 18:51
This week on Blunt Business, we’re diving into two massive legal shifts reshaping cannabis markets on opposite sides of the country. First, we break down Georgia’s major policy overhaul as Governor Brian Kemp signs the "…
$15 Billion Refund? Navigating Retroactive 280E Relief [not-audio_url] [/not-audio_url]

Duration: 24:46
As the federal government moves toward rescheduling marijuana, the cannabis industry is eyeing a massive financial shift: the potential for $15 billion in retroactive tax relief from Section 280E. While the transition to…